Table 3

Overall results.

No. of Subjects


Model

No. of

Contrasts

OMT

Control

Effect

Size

95% CI

P

Median contrasts

Fixed-effects model*

8

318

231

-0.30

-0.47 – -0.13

.001

Random-effects model

8

318

231

-0.31

-0.49 – -0.13

.001

Best-case scenario

8

293

220

-0.37

-0.55 – -0.20

<.001

Worst-case scenario

8

298

221

-0.18

-0.35 – 0.00

.046

Median contrasts, one OMT vs control treatment comparison per trial

Gibson [43] active treatment control and Licciardone [46] placebo control

6

237

181

-0.30

-0.49 – -0.10

.003

Gibson [43] active treatment control and Licciardone [46] no treatment control

6

247

179

-0.39

-0.59 – -0.20

<.001

Gibson [43] placebo control and Licciardone [46] placebo control

6

238

187

-0.26

-0.45 – -0.06

.01

Gibson [43] placebo control and Licciardone [46] no treatment control

6

248

185

-0.35

-0.54 – -0.15

<.001

Median contrasts, Cleary [47] trial excluded

7

310

227

-0.29

-0.47 – -0.12

.001

All contrasts

20

727

520

-0.29

-0.40 – -0.17

<.001


CI denotes confidence interval; OMT, osteopathic manipulative treatment.

*Test for homogeneity, P = .37.

Licciardone et al. BMC Musculoskeletal Disorders 2005 6:43   doi:10.1186/1471-2474-6-43

Open Data